Study supports bisphosphonate use prior to denosumab to prevent loss of bone mineral density in post-menopausal women
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) finds the risk of bone mineral density (BMD) loss after denosumab discontinuation is associated with younger age, high bone ...
Jun 13, 2019
0
1